Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Able View Global (ABLV) Cash & Equivalents (2022 - 2025)

Able View Global's Cash & Equivalents history spans 4 years, with the latest figure at $9.0 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 40.69% to $9.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.0 million through Dec 2025, down 40.69% year-over-year, with the annual reading at $9.0 million for FY2025, 40.69% down from the prior year.
  • Cash & Equivalents came in at $9.0 million for Q4 2025, up from $6.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $15.2 million in Q4 2024 to a low of $5.8 million in Q4 2022.
  • The 4-year median for Cash & Equivalents is $9.0 million (2025), against an average of $9.3 million.
  • Year-over-year, Cash & Equivalents skyrocketed 130.86% in 2023 and then tumbled 40.69% in 2025.
  • Able View Global's Cash & Equivalents stood at $5.8 million in 2022, then surged by 130.86% to $13.3 million in 2023, then rose by 13.98% to $15.2 million in 2024, then crashed by 40.69% to $9.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABLV's Cash & Equivalents are $9.0 million (Q4 2025), $6.3 million (Q2 2025), and $15.2 million (Q4 2024).